Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Argye Elizabeth Hillis MD, MA Associate Editor

Mark Hallett MD Editor-in-Chief

See All Experts

story of the week

Published in Neurology and

Journal Scan / Consensus and Guidelines · February 28, 2023

Use of Symptomatic Medications During Pregnancy in Patients With MS

Multiple Sclerosis (Houndmills, Basingstoke, England)

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Ahmed Obeidat MD, PhD

Multiple Sclerosis (Houndmills, Basingstoke, England)

Developing evidence-based guidelines for the safety of symptomatic drugs in multiple sclerosis during pregnancy and breastfeeding: A systematic review and Delphi consensus

Mult. Scler. 2023 Feb 05;[EPub Ahead of Print], P Iyer, K Wiles, A Ismail, S Nanda, K Murray, S Hughes, HL Ford, OR Pearson, S White, N Bonham, N Hoyle, J Witts, R Middleton, PA Brex, D Rog, R Dobson

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Multiple Sclerosis

Use of Symptomatic Medications During Pregnancy in Patients With MS

Additional Info

Developing evidence-based guidelines for the safety of symptomatic drugs in multiple sclerosis during pregnancy and breastfeeding: A systematic review and Delphi consensus

Further Reading

SGLT2 Inhibitor Use and the Risk of Dementia and Parkinson's Disease in Patients With Type 2 Diabetes

CSF α-Synuclein Seed Amplification Assay in Patients With Atypical Parkinsonian Disorders

Consensus-Based Recommendations for the Diagnosis and Treatment of Anxiety and Depression in Children and Adolescents With Epilepsy

Association of First Antiseizure Medication With Acute Healthcare Utilization in Adults With Newly Diagnosed Epilepsy

Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite Anticoagulation

Hearing Loss and Peripheral Neuropathy and Associations With Balance, and Survival in Older Primary Care Patients

Adverse Effects of Commonly Prescribed Antiseizure Medications in Adults With Newly Diagnosed Focal Epilepsy

FDA Approves Miplyffa for Treatment of Niemann-Pick Disease, Type C

Increased Sighing During Sleep as a Marker of Multiple System Atrophy

Clinical Decision Support Improves Autoimmune/Paraneoplastic Antibody Panel Utilization

FDA Approves Injectable Ocrevus Zunovo for Relapsing, Progressive MS

Recently Updated